Sign In
Buy LLY
$1,231.58
+45.87 (+3.87%)
At Close: Aug 10, 2026
1 Green Flag and 1 Red Flag for Eli Lilly
09:45am, Saturday, 20'th Aug 2022
Should you steer clear of this pharma giant?
Final Trades: Estee Lauder, Eli Lilly, Devon Energy & more
02:19pm, Friday, 19'th Aug 2022
The "Halftime Report" traders give their top picks to watch for the second half.
How Eli Lilly Is Thinning Out the Competition
10:00am, Wednesday, 17'th Aug 2022
The company sees good market signals from its recently launched potential blockbuster drug.
This Growth Stock Has Soared Over 200% Year to Date -- Is It a Buy?
10:15am, Tuesday, 16'th Aug 2022
More than two years into the pandemic, hospitalized patients with severe cases may get a game-changing treatment.
3 Stocks to Buy and Hold Forever
06:11am, Saturday, 13'th Aug 2022
These stocks are keepers.
Ken Fisher's Top 5 Trades in the 2nd Quarter
06:12pm, Thursday, 11'th Aug 2022
Ken Fisher (Trades, Portfolio), CEO and chief investment officer of Fisher Investments, disclosed in a regulatory filing that his firm's top five trades during the second quarter included boosts to it
Jim Cramer breaks down shares of Meta, Micron, Eli Lilly and more
11:23am, Wednesday, 10'th Aug 2022
'Mad Money' host Jim Cramer and the 'Squawk on the Street' team break down stocks to watch following the opening bell on Wednesday.
Eli Lilly Hits Some Bumps in the Road
02:38pm, Tuesday, 09'th Aug 2022
Hit by a spate of bad news, Eli Lilly and Co. ( LLY , Financial) has lost nearly 8% of its market value since July 28. Is it time for investors to join those bailing on the stock or jump in on the dip
Following The Q2 Report, Eli Lilly Is A Hold On Valuation
04:41pm, Friday, 05'th Aug 2022
Eli Lilly reported its Q2 results on Thursday, showing a revenue decline. Shares of Eli Lilly are trading for almost 40 times forward earnings, much higher than most tech companies.
Eli Lilly and Company (LLY) CEO Dave Ricks on Q2 2022 Results - Earnings Call Transcript
04:40pm, Thursday, 04'th Aug 2022
Eli Lilly and Company (NYSE:LLY ) Q2 2022 Earnings Conference Call August 4, 2022 9:00 AM ET Company Participants Kevin Hern - Vice President of Investor Relations Dave Ricks - Chair & Chief Executive
Eli Lilly (LLY) Misses on Q1 Earnings, Lowers Earnings Guidance
03:04pm, Thursday, 04'th Aug 2022
Eli Lilly's (LLY) earnings and sales miss second-quarter estimates. The company lowers its earnings outlook for 2022.
Eli Lilly Q2 results: its Alzheimer's drug could be ‘the biggest drug in history'
12:10pm, Thursday, 04'th Aug 2022
Shares of Eli Lilly & Co (NYSE: LLY) are in the red this morning after the pharmaceutical giant reported weaker-than-expected results for its fiscal second quarter. Key takeaways from Eli Lilly Q2 res
Lilly Updates Conference Call Start Time for Second-Quarter 2022 Financial Results
09:52am, Thursday, 04'th Aug 2022
INDIANAPOLIS , Aug. 4, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will now conduct its second-quarter 2022 financial results investor conference call today at 10 a.m. Eastern time due to t
Eli Lilly CEO David Ricks breaks down second-quarter earnings and drug pipeline
09:24am, Thursday, 04'th Aug 2022
Eli Lilly CEO David Ricks joins CNBC's 'Squawk Box' to react to the pharma company's second-quarter earnings report, which missed Wall Street's estimates.
Eli Lilly (LLY) Lags Q2 Earnings and Revenue Estimates
09:02am, Thursday, 04'th Aug 2022
Lilly (LLY) delivered earnings and revenue surprises of -30.56% and 5.91%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
